JP2014512353A5 - - Google Patents

Download PDF

Info

Publication number
JP2014512353A5
JP2014512353A5 JP2014501814A JP2014501814A JP2014512353A5 JP 2014512353 A5 JP2014512353 A5 JP 2014512353A5 JP 2014501814 A JP2014501814 A JP 2014501814A JP 2014501814 A JP2014501814 A JP 2014501814A JP 2014512353 A5 JP2014512353 A5 JP 2014512353A5
Authority
JP
Japan
Prior art keywords
composition according
virus
protein
antiviral composition
pharmaceutical composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2014501814A
Other languages
English (en)
Japanese (ja)
Other versions
JP2014512353A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/IN2012/000153 external-priority patent/WO2013072917A2/en
Publication of JP2014512353A publication Critical patent/JP2014512353A/ja
Publication of JP2014512353A5 publication Critical patent/JP2014512353A5/ja
Pending legal-status Critical Current

Links

JP2014501814A 2011-03-31 2012-03-05 抗ウイルス組成物 Pending JP2014512353A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IN1126/MUM/2011 2011-03-31
IN1126MU2011 2011-03-31
PCT/IN2012/000153 WO2013072917A2 (en) 2011-03-31 2012-03-05 Antiviral composition

Publications (2)

Publication Number Publication Date
JP2014512353A JP2014512353A (ja) 2014-05-22
JP2014512353A5 true JP2014512353A5 (https=) 2015-04-23

Family

ID=48430291

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2014501814A Pending JP2014512353A (ja) 2011-03-31 2012-03-05 抗ウイルス組成物

Country Status (4)

Country Link
US (1) US20140011735A1 (https=)
EP (1) EP2691106A4 (https=)
JP (1) JP2014512353A (https=)
WO (1) WO2013072917A2 (https=)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN106715949B (zh) * 2014-06-16 2019-03-08 斯威尔Ivf股份有限公司 冲击机
US20190382454A1 (en) * 2015-03-05 2019-12-19 Amrita Therapeutics Limited A modified peptide as an anticancer agent
WO2020006494A1 (en) 2018-06-29 2020-01-02 Fred Hutchinson Cancer Research Center Cell-stored barcoded deep mutational scanning libraries and uses of the same
US11821111B2 (en) 2019-11-15 2023-11-21 Fred Hutchinson Cancer Center Barcoded influenza viruses and deep mutational scanning libraries including the same

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6087163A (en) * 1997-02-06 2000-07-11 The Public Health Research Institute Of The City Of New York, Inc. Mycobacterium tuberculosis specific proteins and genes, mixtures of anitgens and uses thereof
DE69923172T2 (de) * 1998-04-29 2005-12-29 Medac Gesellschaft für klinische Spezialpräparate m.b.H Behandlung einer papillomavirusinfektion durch verwendung von mycobacterium
AU2005285513B2 (en) * 2004-05-25 2011-02-24 Oregon Health And Science University SIV and HIV vaccination using RhCMV- and HCMV-based vaccine vectors
JP2006149234A (ja) * 2004-11-25 2006-06-15 Japan Science & Technology Agency プライム−ブーストワクチン接種法
JP5246730B2 (ja) * 2006-12-08 2013-07-24 独立行政法人理化学研究所 Th1細胞分化促進剤
US10611818B2 (en) * 2007-09-27 2020-04-07 Agilent Technologies, Inc. MHC multimers in tuberculosis diagnostics, vaccine and therapeutics
US9624277B2 (en) * 2010-10-01 2017-04-18 Amrita Therapeutics Limited Anticancer agent

Similar Documents

Publication Publication Date Title
Patel et al. Novel drugs targeting Toll-like receptors for antiviral therapy
PH12018550201A1 (en) Hepatitis b antiviral agents
MX2012007410A (es) Compuestos antivirales novedosos.
JP2018523668A5 (https=)
EA201171376A1 (ru) Производные тиено[2,3-b]пиридина в качестве ингибиторов репликации вируса
CN114901681A (zh) 胰岛素衍生物
JP2015096557A5 (https=)
PH12018550148A1 (en) Hepatitis b antiviral agents
MX2013005478A (es) Compuestos heterociclicos condensados antivirales.
PH12020550065A1 (en) Hepatitis b antiviral agents
ME02400B (me) Policiklična karbamoilpiridonska jedinjenja i njihova farmaceutska upotreba
IL276210B2 (en) Mers-cov vaccine
RU2015109132A (ru) Пролекарственная форма тенофовира и ее фармацевтические применения
IN2014MN01547A (https=)
EA201591213A1 (ru) Вакцины против вируса гепатита b
EA201991174A1 (ru) Комбинация двух противовирусных препаратов для лечения гепатита c
JP2011225596A5 (https=)
GB2503066A8 (en) Combination pharmaceutical composition and methods of treating and preventing the infectious diseases
BR112013028679A2 (pt) inibidores do vírus da hepatite c
JP2014532722A5 (https=)
JP2014512353A5 (https=)
HRP20211749T1 (hr) Pentanske kiseline supstituirane pirolo-[2-3,b]pirimidin-piridinima za liječenje virusnih infekcija influencom
WO2011091319A3 (en) Dendritic cell vaccines
JP2018531880A5 (https=)
EA201491969A1 (ru) Иммуногенные соединения, включающие пептид gp41 вич, связанный с белком-носителем crm197